Recombinant Human LH alpha/beta Heterodimer Protein
R&D Systems, part of Bio-Techne | Catalog # 8899-LH
Key Product Details
Source
Accession #
Structure / Form
Conjugate
Applications
Product Specifications
Source
Ala25-Ser116 ( alpha chain) & Ser21-Leu141 ( beta chain)
Purity
Endotoxin Level
N-terminal Sequence Analysis
Predicted Molecular Mass
SDS-PAGE
Activity
The ED50 for this effect is 0.075-0.75 ng/mL.
Formulation, Preparation and Storage
Carrier Free
What does CF mean?CF stands for Carrier Free (CF). We typically add Bovine Serum Albumin (BSA) as a carrier protein to our recombinant proteins. Adding a carrier protein enhances protein stability, increases shelf-life, and allows the recombinant protein to be stored at a more dilute concentration. The carrier free version does not contain BSA.
What formulation is right for me?In general, we advise purchasing the recombinant protein with BSA for use in cell or tissue culture, or as an ELISA standard. In contrast, the carrier free protein is recommended for applications, in which the presence of BSA could interfere.
Carrier: 8899-LH
Formulation | Lyophilized from a 0.2 μm filtered solution in PBS with BSA as a carrier protein. |
Reconstitution | Reconstitute at 100 μg/mL in sterile PBS. |
Shipping | The product is shipped at ambient temperature. Upon receipt, store it immediately at the temperature recommended below. |
Stability & Storage | Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
|
Carrier Free: 8899-LH/CF
Formulation | Lyophilized from a 0.2 μm filtered solution in sterile PBS. |
Reconstitution | Reconstitute at 100 μg/mL in PBS. |
Shipping | The product is shipped at ambient temperature. Upon receipt, store it immediately at the temperature recommended below. |
Stability & Storage | Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
|
Background: LH alpha/beta Heterodimer
References
- Keutmann, H.T. et al. (1987) Proc. Natl. Acad. Sci. USA 84:2038.
- Keutmann, H.T. et al. (1992) Mol. Endocrinol. 6:904.
- Wilson, C.A. et al. (1990) J. Endocrinol. 125:3.
- Stanton, P.G. et al. (1993) J. Endocrinol. 138:529.
- Stanton, P.G. et al. (1996) Mol. Cell. Endocrinol. 125:133.
- Bergendah, M. and J.D. Veldhuis (2001) Hum. Reprod. 16:1058.
- Choi, J. and J. Smitz (2014) Mol. Cell. Endocrinol. 383:203.
- Marshall, J.C. et al. (1993) Trans. Am. Clin. Climatol. Assoc. 104:31.
- Raju, G.A. et al. (2013) J. Hum. Reprod. Sci. 6:227.
- Alevizaki, M. et al. (2006) Eur. J. Endocrinol. 154:875.
- Moran, F.M. et al. (2013) Menopause 20:329.
- Balen, A.H. (1995) J. R. Soc. Med. 88:339P.
- Blank, S.K. et al. (2006) Hum. Reprod. Update 12:351.
- Webber, K.M. et al. (2007) Clin. Med. Res. 5:177.
- Blair, J.A. et al. (2015) Front. Endocrinol. (Lausanne) 6:45.
Long Name
Additional LH alpha/beta Heterodimer Products
Product Documents for Recombinant Human LH alpha/beta Heterodimer Protein
Product Specific Notices for Recombinant Human LH alpha/beta Heterodimer Protein
For research use only